$24.06
7.55% yesterday
Nasdaq, Aug 12, 10:00 pm CET

BioLife Solutions, Inc. Stock price

$24.06
+2.04 9.26% 1M
-2.28 8.66% 6M
-1.90 7.32% YTD
-1.74 6.74% 1Y
-0.53 2.16% 3Y
+5.73 31.26% 5Y
+22.00 1,067.96% 10Y
+21.26 759.29% 20Y
Nasdaq, Closing price Tue, Aug 12 2025
+1.69 7.55%

Key metrics

Basic
Market capitalization
$1.1b
Enterprise Value
$996.0m
Net debt
positive
Cash
$88.6m
Shares outstanding
47.6m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
11.4 | 10.7
EV/Sales
10.6 | 10.0
EV/FCF
105.6
P/B
3.0
Financial Health
Equity Ratio
87.3%
Return on Equity
-5.8%
ROCE
-1.1%
ROIC
-1.4%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$94.2m | $99.7m
EBITDA
$-1.7m | $21.5m
EBIT
$-4.2m | $-6.4m
Net Income
$-10.4m | $-4.7m
Free Cash Flow
$9.4m
Growth (TTM | estimate)
Revenue
-28.8% | 21.2%
EBITDA
96.0% | 590.2%
EBIT
90.9% | 10.0%
Net Income
83.5% | 76.8%
Free Cash Flow
142.8%
Margin (TTM | estimate)
Gross
62.6%
EBITDA
-1.8% | 21.6%
EBIT
-4.4%
Net
-11.1% | -4.7%
Free Cash Flow
10.0%
More
EPS
$-0.2
FCF per Share
$0.2
Short interest
12.5%
Employees
159
Rev per Employee
$520.0k
Show more

Is BioLife Solutions, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

BioLife Solutions, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a BioLife Solutions, Inc. forecast:

15x Buy
94%
1x Hold
6%

Analyst Opinions

16 Analysts have issued a BioLife Solutions, Inc. forecast:

Buy
94%
Hold
6%

Financial data from BioLife Solutions, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
94 94
29% 29%
100%
- Direct Costs 35 35
59% 59%
37%
59 59
26% 26%
63%
- Selling and Administrative Expenses 50 50
33% 33%
53%
- Research and Development Expense 7.72 7.72
55% 55%
8%
-1.66 -1.66
96% 96%
-2%
- Depreciation and Amortization 2.53 2.53
45% 45%
3%
EBIT (Operating Income) EBIT -4.19 -4.19
91% 91%
-4%
Net Profit -10 -10
83% 83%
-11%

In millions USD.

Don't miss a Thing! We will send you all news about BioLife Solutions, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

BioLife Solutions, Inc. Stock News

Neutral
Seeking Alpha
4 days ago
BioLife Solutions, Inc. (NASDAQ:BLFS ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Roderick de Greef - CEO & Chairman Troy Wichterman - Chief Financial Officer Conference Call Participants Anna Snopkowski - KeyBanc Capital Markets Inc., Research Division Chad M. Wiatrowski - TD Cowen, Research Division Matthew Jay Stanton - Jefferies LLC, Research Division Yi...
Neutral
PRNewsWire
5 days ago
Cell Processing revenue of $23.0 million, up 28% over Q2 2024 GAAP gross margin of 62%  and non-GAAP adjusted gross margin of 65% GAAP net loss of $15.8 million, inclusive of a non-cash $15.5 million IPR&D expense, and non-GAAP adjusted EBITDA of $6.1 million or 24% of revenue Raises full-year 2025 revenue guidance to $100.0 million - $103.0 million, and full-year 2025 Cell Processing revenue g...
Neutral
PRNewsWire
15 days ago
BOTHELL, Wash. , July 28, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced that as part of a larger round of financing it has purchased $2 million of convertible notes in Pluristyx, Inc. ("Pluristyx"), a Seattle based developer of innovative induced p...
More BioLife Solutions, Inc. News

Company Profile

BioLife Solutions, Inc. engages in the development, manufacture, and marketing of biopreservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1998 and it is headquartered in Bothell, WA.

Head office United States
CEO Roderick Greef
Employees 159
Founded 1987
Website www.biolifesolutions.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today